Media-OutReach Newswire ZJLD Group FY2024 Performance Shows High-Quality and Stable Development with a Remarkable 116.3% Surge in Operating Cash Flow
HKBU-led research develops novel drug delivery system for Gouteng compound for Alzheimer’s disease treatment 1.